Search results for "crispr"
A graphene-enhanced space industry
Graphene, a single layer of carbon atoms arranged in a two-dimensional honeycomb lattice, is making significant inroads into the space industry.
The future of tech, as told by CES
It’s day two of digital CES and the innovations are well underway, with companies big and small from all over introducing their latest developments and breakthroughs to their peers and customers. Among the highlights was a keynote from CTA President and CEO Gary Shapiro and CES Vice President Karen Chupka, find out here what they had to say.
Could genome editing revolutionise agriculture?
In this webinar, Technology Analyst Dr Michael Dent will present an overview of IDTechEx's recent research into the crop biotechnology industry, focusing on the potential of genome editing to revolutionise the field.
Helping plants in the face of climate change
As the world heats up, plants face a dilemma – the same tiny holes they have to open to exchange gases also let out water. They can close the holes, called stomata, to stay hydrated in hotter, drier conditions but, in doing so, may miss out on critical carbon dioxide.The question for the Bergmann Lab at Stanford University is how this dilemma will play out as increasing portions of the world’s plants experience consistently warmer, dr...
Maximising CRISPR-based tool for diagnosing disease
The team that first unveiled the rapid, inexpensive, highly sensitive CRISPR-based diagnostic tool called SHERLOCK has greatly enhanced the tool’s power, and has developed a miniature paper test that allows results to be seen with the naked eye — without the need for expensive equipment.The SHERLOCK team developed a simple paper strip to display test results for a single genetic signature, borrowing from the visual cues common in preg...
CRISPR/Cas9-guided activation to investigate X syndrome neurons
Fragile X syndrome is the most frequent cause of intellectual disability in males, affecting one out of every 3,600 boys born. The syndrome can also cause autistic traits, such as social and communication deficits, as well as attention problems and hyperactivity. Currently, there is no cure for this disorder.Fragile X syndrome is caused by mutations in the FMR1 gene on the X chromosome, which prevent the gene’s expression.
The coming of age of gene therapy
After three decades of hopes tempered by setbacks, gene therapy—the process of treating a disease by modifying a person’s DNA—is no longer the future of medicine, but is part of the present-day clinical treatment toolkit. The journalScienceprovides an in-depth and timely review of the key developments that have led to several successful gene therapy treatments for patients with serious medical conditions.
Genome editing improves T-cells to attack cancer
Researchers at Cardiff University have found a way to boost the cancer-destroying ability of the immune system’s T-cells, offering new hope in the fight against a wide range of cancers.Using CRISPR genome editing, the team took the genetic engineering of killer T-cells one step further by removing their non-cancer specific receptors and replacing them with ones that would recognise specific cancer cells and destroy them.
Disruptive bioengineering could stop cancer cells
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed a new platform based on the CRISPR/Cas9 technology, to alter the way human cells respond to external signals, and provide new opportunities for stopping cancer cells from developing.
Synthetic organs, nanobots and DNA ‘scissors’: the future of medicine
Nanobots that patrol our bodies, killer immune cells hunting and destroying cancer cells, biological scissors that cut out defective genes: these are just some of technologies that Cambridge researchers are developing which are set to revolutionise medicine in the future.In a new film to coincide with the recent launch of the Cambridge Academy of Therapeutic Sciences, researchers discuss some of the most exciting developments in medical research ...